Improving Bone Health in Patients with Metastatic Prostate Cancer with the Use of Algorithm-Based Clinical Practice Tool

Background: The bone health of patients with locally advanced and metastatic prostate cancer is at risk from treatment-related bone density loss and skeletal-related events from metastatic disease in bones. Evidence-based guidelines recommend using denosumab or zoledronic acid at bone metastasis-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Kamal Kant, Johnson, Eric D., Butler, Katerina, Li, Haoran, Boucher, Kenneth M., Gupta, Sumati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778212/
https://www.ncbi.nlm.nih.gov/pubmed/36547269
http://dx.doi.org/10.3390/geriatrics7060133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778212/
https://www.ncbi.nlm.nih.gov/pubmed/36547269
http://dx.doi.org/10.3390/geriatrics7060133

Ejemplares similares